期刊文献+

猪细小病毒SC-1株VP2基因的定点突变及其对该基因表达的影响 被引量:1

Site-directed mutations of VP2 gene of porcine parvovirus strain SC-1 and its effect on expression of the gene
在线阅读 下载PDF
导出
摘要 根据GenBank中的猪细小病毒(PPV)VP2基因序列设计并合成了2对突变引物,对PPV SC-1株VP2基因进行了定点突变。利用重叠延伸PCR技术分别将VP2蛋白中第402位(A)和214位(B)的半胱氨酸突变为精氨酸,并定向克隆入真核表达载体pPI-2.EGFP中,构建含报告基因EGFP的重组质粒pPI-2.EGFP.VP2(A)、pPI2.EGFP.VP2(B);利用脂质体介导法将上述重组质粒转染COS-7细胞,从而研究该突变对VP2基因表达的影响。结果显示,成功构建了含突变体及EGFP的真核表达载体;在倒置荧光显微镜下,突变后的质粒转染呈现不同的荧光信号,A样品的荧光呈颗粒状分布于细胞中,而B样品与阳性对照相似,荧光信号均匀分布于细胞中。提示,突变的引入是导致表达差异的主要原因。 Based on the VP2 gene sequence of porcine parvovirus (PPV) available in GenBank, two pairs of primers were designed and synthesized to modify VP2 gene of the PPV SC 1 strain . Using overlap ping extension PCR,the codons encoding cysteine of VP2 protein in 214th and 402nd site were mutated into the codons encoding arginine, then the mutant VP2 gene was cloned into eukaryotic expression vector pPI-2. EGFP with green fluorescent protein(GFP) gene to construct the recombinant plasmids pPI-2. EG FP. VP2(A) and pPI-2. EGFP. VP2(B). To elucidate the effect of the mutation on the expression of the mutants,the COS7 cells were transfected with the plasmids, via mediation by LIPOFECTION Reagent 2000. The result showed that the recombinant plasmids pPI-2. EGFP. VP2(A) and pPI-2. EGFP. VP2(B) were constructed successfully. The granular enhanced green fluorescent protein(EGFP) in the cells transfected by pPI-2. EGFP. VP2(A) was observed. This observation indicated that the mutants were introduced successfully into the target sites and the eukaryotic expression vectors containing both mutant and EGFP were constructed. The introduction of mutant was the main reason for the differential expression of plasmids.
出处 《中国兽医科学》 CAS CSCD 北大核心 2008年第7期563-568,共6页 Chinese Veterinary Science
基金 国家自然科学基金项目(30500019) 四川省科技厅科技攻关计划项目(2004D004)
关键词 猪细小病毒 VP2基因 定点突变 真核表达 porcine parvovirus VP2 gene site directed mutation eukaryotic expression
  • 相关文献

参考文献17

  • 1BERGERON J, HEBERT B, TIJSSEN P. Genome organization of the Kresse strain of porcine parvovirus:identification of the allotropic determinant and comparison with those of NADL-2 and field isolates[J]. J Virol, 1996,70(4) : 2508-2515.
  • 2NARITA M,IMADA T,TAKADA M,etal. Detection of reactivating pseudorabies virus in tissue by immunoperoxidase technique[J].J Comp Pathol,1989,101(2):151-159.
  • 3ADRIAAN F,CHRISTINE J,PALOMA R,et al. A novel re eombinant virus-like particle vaccine for prevention of porcine parvovirus induced reproductive failure [J].Vaccine, 2006,24 (24) :5481-5490.
  • 4XU Yi-gang, LI Yi-jing. Induction of immune responses in mice after intragastric administration of Lactobacillus casei producing porcine parvovirus VP2 protein[J]. Appl Environ Microbiol,:7007,73(21) :7041-7047.
  • 5罗燕,郭万柱,徐志文,刘艳丽,殷华平,王新,王小玉,苟琳.含绿色荧光蛋白基因的猪细小病毒病-伪狂犬病重组病毒的构建[J].畜牧兽医学报,2005,36(10):1064-1068. 被引量:11
  • 6MARTINE Z C,DALSQAARD K,LOPEZ DE TURISO J A, et al. Production of porcine parvovirus empty capsid with high immunogenic activity[J]. Vaccine, 1992,10(10) : 684-690.
  • 7SEDLIK C,SARON M F, SARRASECA J, et al. Recombinant parvovirus-like particles as an antigen carrier: a novel nonrepli cative exogenous antigen to elicit protective antiviral cytotoxic T cells[J]. Immunology, 1997,94(14) :7503-7508.
  • 8MORON V G,RUEDA P,SEDLIK C,etal. In vivo ,dendritic cells can cross present virus-like particles using an endosome-to-cytosol pathway[J]. J Immunol,2003,171(5):2242-2250.
  • 9SEDLIK C,DRIDI A, DERIAUD E,et al. Intranasal delivery of recombinant parvovirus-like particles elicits cytotoxic T- cell and neutralizing antibody responses[J]. Vaccine Antiviral Agents, 1999,73 (4) : 2739-2744.
  • 10SEDLIK C, SARRASECA J, RUEDA P, et al. Immunogenicity of poliovirus B and T cell epitopes presented by hybrid porcine parvovirus particles [J]. J Gen Virol, 1995,76 (9) : 2361-2368.

二级参考文献56

  • 1晁开,何丹,杨慧,张众,林晴,郭蔼光,黄华樑.抗膀胱癌重组免疫毒素的可溶性表达及其抗肿瘤活性[J].细胞与分子免疫学杂志,2004,20(5):568-571. 被引量:3
  • 2徐志文,郭万柱,朱玲,唐善虎.伪狂犬病病毒3基因缺失株(SA215)的遗传稳定性研究[J].畜牧兽医学报,2004,35(6):694-697. 被引量:8
  • 3李容,熊冬生,许元富,邵晓枫,范冬梅,朱祯平,杨纯正.抗KDR单链抗体的构建、表达及生物学活性鉴定[J].细胞与分子免疫学杂志,2005,21(1):39-42. 被引量:4
  • 4侯云德.动物病毒载体与基因治疗的现状和前景[J].生物工程进展,1994,14(2):6-10. 被引量:8
  • 5Kreitman RJ.Immunotoxins in cancer therapy[J].Curr Opin Immunol,1999,11(5):570-578.
  • 6Rajagopal V,Pastan I,Kreitman RJ.A form of anti-Tac(Fv) which is both single-chain and disulfide stabilized:comparison with its single-chain and disulfide-stabilized homologs[J].Protein Eng,1997,10(12):1453-1459.
  • 7Brinkmann U,Pai LH,FitzGerald DJ,et al.B3(Fv)-PE38KDEL,a single-chain immunotoxin that causes complete regression of a human carcinoma in mice[J].Proc Natl Acad Sci USA,1991,88(19):8616-8620.
  • 8Pai LH,Batra JK,FitzGerald DJ,et al.Antitumor effects of B3-PE and B3-LysPE40 in a nude mouse model of human breast cancer and the evaluation of B3-PE toxicity in monkeys[J].Cancer Res,1992,52(11):3189-3193.
  • 9Brinkmann U,Reiter Y,Jung SH,et al.A recombinant immunotoxin containing a disulfide-stabilized Fv fragment[J].Proc Natl Acad Sci USA,1993,90(16):7538-7542.
  • 10Pastan I,Lovelace ET,Gallo MG,et al.Characterization of monoclonal antibodies B1 and B3 that react with mucinous adenocarcinomas[J].Cancer Res,1991,51(14):3781-3787.

共引文献167

同被引文献1

引证文献1

二级引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部